Aplisens SA (APN) · Q2 2026 results and valuation

At −0.3% growth a year (3-year revenue growth), the model's fair value is 15.43 zł a share — the stock trades 15% above it. Today's price assumes 1.8% growth a year.

1. Fading

   Inventory growth is driven by large-batch and serial production, which creates a risk of value loss for materials and semi-finished products no longer used in current production.

   Source quote

   “Purchased in large batches and produced in series, they create an increase in inventory. The wide range of finished products offered by the Group generates a high demand for production materials and semi-finished products. The risk of impairment primarily concerns these materials and semi-finished products which, due to changes in technology and market demand, are not used in current production.”

Restrained for a company report — about as upbeat as in Q2 2025. Periodic reports carry legally required risk wording, so their tone moves little and is a weak signal.

Sentences that drove the tone

“These factors may have a negative impact on the Company's financial results and market value.”

“The second largest market is the European Union, where the Company recorded the highest revenue growth – i.e., an increase of over PLN 1 million (+7.8% y/y) to a level of nearly PLN 14.6 million.”